{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:45:14Z","timestamp":1784306714627,"version":"3.55.0"},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.7927","type":"journal-article","created":{"date-parts":[[2017,5,14]],"date-time":"2017-05-14T18:11:39Z","timestamp":1494785499000},"page":"1169-1173","source":"Crossref","is-referenced-by-count":12,"title":["Graves' Disease in Pediatric and Elderly Patients with 22q11.2 Deletion Syndrome"],"prefix":"10.2169","volume":"56","author":[{"given":"Yoko","family":"Ueda","sequence":"first","affiliation":[{"name":"The First Department of Medicine, Wakayama Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Uraki","sequence":"additional","affiliation":[{"name":"The First Department of Medicine, Wakayama Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Inaba","sequence":"additional","affiliation":[{"name":"The First Department of Medicine, Wakayama Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Nakashima","sequence":"additional","affiliation":[{"name":"The First Department of Medicine, Wakayama Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ariyasu","sequence":"additional","affiliation":[{"name":"The First Department of Medicine, Wakayama Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Iwakura","sequence":"additional","affiliation":[{"name":"The First Department of Medicine, Wakayama Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ota","sequence":"additional","affiliation":[{"name":"The First Department of Medicine, Wakayama Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Furuta","sequence":"additional","affiliation":[{"name":"The First Department of Medicine, Wakayama Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nishi","sequence":"additional","affiliation":[{"name":"The First Department of Medicine, Wakayama Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Akamizu","sequence":"additional","affiliation":[{"name":"The First Department of Medicine, Wakayama Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. McDonald-McGinn DM, Sullivan KE, Marino B, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers 1: 15071, 2015.","DOI":"10.1038\/nrdp.2015.71"},{"key":"2","unstructured":"2. Burnside RD. 22q11.21 Deletion Syndromes: a review of proximal, central, and distal deletions and their associated features. Cytogenet Genome Res 146: 89-99, 2015."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Astor MC, L\u00f8v\u00e5s K, Debowska A, et al. Epidemiology and health related quality of life in hypoparathyroidism in Norway. J Clin Endocrinol Metab 101: 3045-3053, 2016.","DOI":"10.1210\/jc.2016-1477"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Gennery AR, Barge D, O'Sullivan JJ, Flood TJ, Abinun M, Cant AJ. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child 86: 422-425, 2002.","DOI":"10.1136\/adc.86.6.422"},{"key":"5","unstructured":"5. Akamizu T, Mori T, Nakao K. Pathogenesis of Graves' disease: molecular analysis of anti-thyrotropin receptor antibodies. Endocr J 44: 633-646, 1997."},{"key":"6","unstructured":"6. Brown JJ, Datta V, Browning MJ, Swift PG. Graves' disease in DiGeorge syndrome: patient report with a review of endocrine autoimmunity associated with 22q11.2 deletion. J Pediatr Endocrinol Metab 17: 1575-1579, 2004."},{"key":"7","unstructured":"7. Ham Pong AJ, Cavallo A, Holman GH, Goldman AS. DiGeorge syndrome: long-term survival complicated by Graves disease. J Pediatr 106: 619-620, 1985."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kawame H, Adachi M, Tachibana K, et al. Graves' disease in patients with 22q11.2 deletion. J Pediatr 139: 892-895, 2001.","DOI":"10.1067\/mpd.2001.119448"},{"key":"9","unstructured":"9. Kawamura T, Nimura I, Hanafusa M, et al. DiGeorge syndrome with Graves' disease: A case report. Endocr J 47: 91-95, 2000."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Zemble R, Luning Prak E, McDonald K, McDonald-McGinn D, Zackai E, Sullivan K. Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome). Clin Immunol 136: 409-418, 2010.","DOI":"10.1016\/j.clim.2010.04.011"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Rapoport B, McLachlan SM. Graves' hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease. J Clin Endocrinol Metab 99: 4060-4061, 2014.","DOI":"10.1210\/jc.2014-3011"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Kappler JW, Roehm N, Marrack P. T-cell tolerance by clonal elimination in the thymus. Cell 49: 273-280, 1987.","DOI":"10.1016\/0092-8674(87)90568-X"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. McLean-Tooke A, Barge D, Spickett GP, Gennery AR. Immunologic defects in 22q11.2 deletion syndrome. J Allergy Clin Immunol 122: 362-367, 2008.","DOI":"10.1016\/j.jaci.2008.03.033"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sullivan KE, McDonald-McGinn D, Zackai EH. CD4(+) CD25(+) T-cell production in healthy humans and in patients with thymic hypoplasia. Clin Diagn Lab Immunol 9: 1129-1131, 2002.","DOI":"10.1128\/CDLI.9.5.1129-1131.2002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Klocperk A, Grecov\u00e1 J, \u0160i\u0161mov\u00e1 K, Kayserov\u00e1 J, Fro\u00f1kov\u00e1 E, \u0160ediv\u00e1 A. Helios expression in T-regulatory cells in patients with di George Syndrome. J Clin Immunol 34: 864-870, 2014.","DOI":"10.1007\/s10875-014-0071-y"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ueda S, Oryoji D, Yamamoto K, et al. Identification of independent susceptible and protective HLA alleles in Japanese autoimmune thyroid disease and their epistasis. J Clin Endocrinol Metab 99: E379-E383, 2014.","DOI":"10.1210\/jc.2013-2841"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chen PL, Fann CS, Chu CC, et al. Comprehensive genotyping in two homogeneous Graves' disease samples reveals major and novel HLA association alleles. PLoS One 6: e16635, 2011.","DOI":"10.1371\/journal.pone.0016635"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Choi JH, Shin YL, Kim GH, et al. Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome. Horm Res 63: 294-299, 2005.","DOI":"10.1159\/000086745"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Piliero LM, Sanford AN, McDonald-McGinn DM, Zackai EH, Sullivan KE. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood 103: 1020-1025, 2004.","DOI":"10.1182\/blood-2003-08-2824"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Gennery AR. Immunological aspects of 22q11.2 deletion syndrome. Cell Mol Life Sci 69: 17-27, 2012.","DOI":"10.1007\/s00018-011-0842-z"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T cells. Nat Immunol 4: 350-354, 2003.","DOI":"10.1038\/ni906"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sullivan KE, McDonald-McGinn DM, Driscoll DA, et al. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad\/velocardiofacial syndrome\/conotruncal anomaly face syndrome). Arthritis Rheum 40: 430-436, 1997.","DOI":"10.1002\/art.1780400307"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Watanabe N, Wang YH, Lee HK, et al. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 436: 1181-1185, 2005.","DOI":"10.1038\/nature03886"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Gonz\u00e1lez-Amaro R, Marazuela M. T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity. Endocrine 52: 30-38, 2016.","DOI":"10.1007\/s12020-015-0759-7"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Alimohammadi M, Bj\u00f6rklund P, Hallgren A, et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med 358: 1018-1028, 2008.","DOI":"10.1056\/NEJMoa0706487"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/10\/56_56.7927\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T12:39:46Z","timestamp":1569328786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/10\/56_56.7927\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.7927","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}